Navigation Links
Ultroz Elite Wearable Ultrasonic Therapy System was Named as Finalist in the 2013 Medical Design Excellence Awards
Date:4/2/2013

TRUMBULL, Conn., April 2, 2013 /PRNewswire/ -- ZetrOZ, Inc. (www.zetroz.com) announced today that its Ultroz Elite Wearable Ultrasonic Therapy System has been selected as a finalist in the 15th Annual Medical Design Excellence Awards competition. The Ultroz Elite Wearable Ultrasonic Therapy System is the first of its kind - a miniaturized therapeutic ultrasound system designed and engineered to reduce swelling, relieve pain, speed healing and enhance athletic performance.  The device is about the size of an ipod and can be worn during normal activity. The Ultroz Elite is recommended by top Equine veterinarians and physical therapists worldwide.  ZetrOZ, Inc. is currently awaiting FDA approval and CE mark for the human version of its wearable ultrasound therapy system.

(Photo: http://photos.prnewswire.com/prnh/20130402/NY87686 )

The Medical Design Excellence Awards (www.MDEAwards.com) are the industry's premier design awards competition and is the only awards program exclusively recognizing contributions and advances in the design of medical products. Entries are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions improving healthcare delivery and changing traditional medical attitudes or practices, features providing enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so the product meets its clinical objectives.

A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics.

"We are honored to be recognized by the MDEA judges," said Bryant Guffey , CEO of ZetrOZ, Inc. "The widespread adoption of our wearable ultrasound systems in the medical veterinary community and on top equine athletes has been a fantastic and rewarding experience. We're looking forward to introducing the product for human use later this year."

Finalists in each of the competition's ten categories were officially announced in the April issue of Medical Device and Diagnostic Industry (www.mddionline.com) magazine. The winners will be announced on June 19, 2013, during a cocktail reception starting at 4:30 pm at the Marriott Hotel in downtown Philadelphia. The ceremony will be held in conjunction with the 30th MD&M East event (www.MDMEast.com) at the Pennsylvania Convention Center, June 19, 2013. MDEA-winning products will be honored at the ceremony with Bronze, Silver, or Gold-level awards in each category. One Gold -winning product will be awarded 'Best-in-Show'.

The Medical Design Excellence Awards are underwritten and presented by UBM Canon, the global advanced manufacturing and MedTech authority, and by Medical Device and Diagnostic Industry (MD+DI), the industry's central source for late breaking news, information, and business intelligence.

For more information about the Medical Design Excellence Awards, visit www.MDEAwards.com, or e-mail mdea@ubm.com.

Media Contact:
JoAnne Guarino
888-202-9831
jguarino@zetroz.com


'/>"/>
SOURCE ZetrOZ, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Domain Associates and Elite Consulting Collaborate to Create and Invest in Life Science Companies in China
2. Elite Companies Excel by Using Customer Complaint Data to Drive Improvement in Service and Product Quality
3. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
4. Elektas Advanced Versa HD System to Begin Treating Cancer Patients at New Swiss Radiotherapy Clinic
5. Professional Therapy Associates Study Supports Findings: Physical Therapy Beneficial in Treating Office Workers with Lower Back Pain
6. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
7. Surveyed U.S. and European Neurologists Agree that a Therapys Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
8. Denmarks Odense University Hospital Orders Elektas New Versa HD Linear Accelerator for Radiotherapy Treatment of Patients with Cancer
9. Data on ElectroCores Vagal Nerve Stimulation Therapy GammaCore Selected for an Oral Presentation at the 65th American Academy of Neurology Annual Meeting
10. Dynamic Healthcare Services Acquires the operating assets of APO2, a Provider of Home Medical Equipment and Respiratory Therapy Products and Services in Hazleton, PA
11. MolecularHealth demonstrates Personalized Cancer Therapy Solutions at 2013 CeBIT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017 On March 28, the ... treat adult patients with relapsing forms of multiple sclerosis ... the first drug approved by the FDA for PPMS. ... care professional.  "Multiple sclerosis can have ... Billy Dunn , M.D., director of the Division of ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, ... of USD 55.8 billion by 2025. The projection takes into consideration the ... and a more open approach towards cannabis products around the world. In ... , North Dakota , Ohio , ...
(Date:3/29/2017)... , March 29, 2017 FinancialBuzz.com News ... The U.S. ... According to a new report published by New Frontier Data, the ... The accelerating pace of cannabis legalization in the United ... cannabis, are considered to be a major factor that drives growth ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Chicago, Illinois (PRWEB) , ... March 29, 2017 ... ... Visio Stencils Device Library for documenting and diagramming network and data center assets ... , NetZoom subscribers can request new equipment shapes for free and download ...
(Date:3/29/2017)... ... , ... Immunotherapy has emerged as one of the most promising options for ... the next revolution in our fight against this complex disease. One of the most ... inhibitors such as PD-1 and PD-L1 inhibitors. , While a few single analyte immunohistochemistry ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the ... the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony ... Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies ... directly address the resolution to globally reduce the harmful use of alcohol set ... FDA and TTB approved ingredients that when infused into alcohol, renders the alcohol ...
Breaking Medicine News(10 mins):